EichorEICHOR
Location: Rozzano Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Rozzano

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Me
Phase 2 · Istituto Clinico Humanitas · Gruppo Oncologico del Nord-Ovest · NCT07485296Neurosurgical Outcome Network
Phase N/A · IRCCS Istituto Clinico Humanitas · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06724029Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3800003 · Sanofi · NCT06867094This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · IRCCS Istituto Clinico Humanitas · Pfizer · NCT07028853A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · IRCCS Istituto Clinico Humanitas · Takeda · NCT06747351A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · Istituto Clinico Humanitas · Hoffmann-La Roche · NCT05987449A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Humanitas Research Hospital · Takeda · NCT07108283A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · Research Site · AstraZeneca · NCT07571746A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relaps
Phase 1/Phase 2 · Istituto Clinico Humanitas · Bristol-Myers Squibb · NCT07325136A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Humanitas · Eli Lilly and Company · NCT07483099Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · Istituto Clinico Humanitas · Italian Sarcoma Group · NCT04845893Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases
NA · IRCCS Istituto Clinico Humanitas · Istituto Clinico Humanitas · NCT05545007LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Humanitas · Eli Lilly and Company · NCT07415044Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormon
Phase N/A · Istituto Clinico Humanitas · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06805812A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · IRCCS Istituto Clinico Humanitas /ID# 256684 · AbbVie · NCT06109272A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Istituto Clinico Humanitas · Janssen Research & Development, LLC · NCT07499232Critical Illness Weakness Outside the Intensive Care Unit.
Phase N/A · Humanitas Research Institute · Istituto Clinico Humanitas · NCT07478367Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA
NA · IRCCS Humanitas · Lionhealth Srl Società Benefit · NCT07433946A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · IRCCS Istituto Clinico Humanitas · Pfizer · NCT05895786Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
NA · Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04587856Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Humanitas · Eli Lilly and Company · NCT06937086A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · IRCCS Istituto Clinico Humanitas · Hoffmann-La Roche · NCT07416526Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
Phase N/A · Istituto Clinico Humanitas, U.O. Ematologia · Fondazione Italiana Linfomi - ETS · NCT05816850A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Istituto Clinico Humanitas · Daiichi Sankyo · NCT06330064LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398External Validation of the BREF Models
Phase N/A · IRCCS Humanitas Research Hospital · Istituto Clinico Humanitas · NCT06669312A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · Irccs Humanitas Research Hospital · BeOne Medicines · NCT06427941A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Investigational Site Number : 3800009 · Sanofi · NCT06290128
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.